Marker Therapeutics, Inc. (MRKR)

2.10 +0.06 (+2.94%) USD  |  NASDAQ  |  Jan 23, 16:00
2.09 -0.01 (-0.48%) After-Hours: 20:00
More

Marker Therapeutics Preferred Stock (10 Year Growth)

Preferred Stock (10 Year Growth) Chart

View Preferred Stock (10 Year Growth) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Stock (10 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Stock (10 Year Growth) Range, Past 5 Years

View Preferred Stock (10 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Stock (10 Year Growth) Benchmarks

View Preferred Stock (10 Year Growth) Benchmarks
Start Trial
ADMA Biologics, Inc. --
Viridian Therapeutics, Inc. --
Kiniksa Pharmaceuticals International Plc --
Neurocrine Biosciences, Inc. --
AIM ImmunoTech, Inc. --